Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02918175 · ClinicalTrials.gov registry record · NA

Mobile Health Behavioral Intervention in Patients With Heart Failure and Diabetes Mellitus

A NA study, sponsored by Duke University.

Completed
Registry status
NA
Development phase
187
Enrollment target

NCT02918175: Completed NA study, sponsored by Duke University.

NCT02918175 is a NA study that has completed, run by Duke University. The registered enrollment target is 187 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02918175, a NA study, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
187 participants
Enrollment target

Study Summary

The overall objective of this study is to test a personalized mHealth intervention designed to increase physical activity and improve medication adherence in subjects with heart failure and diabetes mellitus. The study will leverage consumer technology as both an intervention and as a tool for data collection.

Primary Outcome

Increased activity

Interventions

  • BEHAVIORAL mHealth

Trial Details

FieldValue
Enrollment Target 187 participants
Start Date 2017-08-02
Est. Completion 2020-09-09
Phase NA
Duke University

1,725 total trials

What the finished NCT02918175 record still lists

NCT02918175 is an interventional study that assigns participants to a tested intervention. The registered 187 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower).

The record links to 0 conditions, and to 1 intervention - of which mHealth is the first listed.

NCT02918175 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02918175 about?

NCT02918175 is a clinical study titled "Mobile Health Behavioral Intervention in Patients With Heart Failure and Diabetes Mellitus". The overall objective of this study is to test a personalized mHealth intervention designed to increase physical activity and improve medication adherence in subjects with heart failure and diabetes mellitus. The study will leverage consumer technology as both an intervention and as a tool for data ...

What is the current status of trial NCT02918175?

This trial is currently completed. It is a NA study. The enrollment target is 187 participants. The study started on 2017-08-02. Estimated completion is 2020-09-09.

What interventions are being tested in trial NCT02918175?

The interventions under investigation include: mHealth (BEHAVIORAL).

Who is sponsoring clinical trial NCT02918175?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02918175's enrollment target sits among peer trials

187 579th of 2000 higher than 1,422 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06153251 · 187 participants · Phase 1

    A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma

  • NCT06254898 · 187 participants · NA

    Use of Incentives for Stressful Medical Procedures

  • NCT07062237 · 187 participants · NA

    A Randomized Clinical Trial Comparing Embryo Euploidy Rates Following Ultrashort Versus Standard Abstinence

  • NCT07217574 · 187 participants

    Program in Oncology for Tribal Health Systems.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02918175, the US trial registry maintained by the National Library of Medicine. NCT02918175 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.